Fore Kopi Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 9.3× UBC Medical Indonesia Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (1.89M versus 817.3K). Which is the better fit depends on your goals.
| FORE | LABS | |
|---|---|---|
Market Cap | 5.44T | 584.6B |
Volume | 1.89M | 817.3K |
Lot | 18.9K | 8.17K |
Turnover | 1.15B | 120.01M |
Average Price | 609.92 | 146.84 |
Value | 1.15B | 120.01M |
Indicative Equilibrium Price | 615 | 146 |
Indicative Equilibrium Volume | 1.29K | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →